NeuroDerm Announces Additions to Management Team

REHOVOT, Israel, July 06, 2016 -- (Healthcare Sales & Marketing Network) -- NeuroDerm Ltd. (NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) disorders, today announced the appointments of Tami Yardeni as Chie... Biopharmaceuticals, Devices, Neurology, PersonnelNeuroDerm, ND0612H, Parkinson’s disease, Levodopa, Carbidopa

Source: HSMN NewsFeed - July 6, 2016 Category: Pharmaceuticals Source Type: news